Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of pemetrexed plus oxaliplatin in advanced biliary tract cancer after gemcitabine + cisplatin failure
KCT0008608Phase 2Not yet recruiting
- Sponsor
- Chong Kun Dang
- Start
- Jul 2023
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed, oxaliplatin in cholangiocarcinoma (CCA), gallbladder cancer, Periampullary Carcinoma, sponsored by Chong Kun Dang. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
pemetrexedoxaliplatin
03
Conditions
cholangiocarcinoma (CCA)gallbladder cancerPeriampullary Carcinoma
Beyond the preview
Go deeper on KCT0008608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008608.